Abstract

Development of serotype-specific monoclonal antibodies against botulinum neurotoxins A, B and E, based on a trivalent immunization protocol and simultaneous differential robotic screen

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call